Capital Structure: Value based mangement in the Pharmaceutical and Biotechnology sector - Dissertation Example

….Page 29 Figure 15…………………………………………………………….Page 30 Figure 16…………………………………………………………….Page 31 Figure 17…………………………………………………………….Page 33 Figure 18…………………………………………………………….Page34 Figure 19…………………………………………………………….Page 35 Figure 20…………………………………………………………….

Page 36 Figure 21…………………………………………………………….Page 37 Figure 22…………………………………………………………….Page 38 Figure 23…………………………………………………………….Page 40 Figure 24…………………………………………………………….Page 40 Figure 25…………………………………………………………….Page 40-41 Figure 26…………………………………………………………….

Page 41 Figure 27…………………………………………………………….Page 41-42 Figure 28…………………………………………………………….Page 42 Figure 29………………………………………………………….. .Page 42 Figure 30…………………………………………………………….Page 42-43 Figure 31……………………………………………………………..Page 47 Figure 32……………………………………………………………….

Page 47 Figure 33……………………………………………………………….Page 48 Figure 34……………………………………………………………….Page 53 Figure. The overall purpose of research is to determine the relational aspects of pre-established variables. The biotechnological industry is one that has become increasingly popular over the last two decades, especially so in South Africa, as advancements in the fields of medicine, food and agriculture, and forensics are achieved within this field of study (Tong, 2004).

This research will focus exclusively on the field of pharmaceutical technological growth within the biotechnological industry. The most basic definition of biotechnology describes it as the application regarding information of living systems for use in an industrial capacity (Tong, 2004) and this field of research within the context of pharmaceutical developments has the potential to contribute significantly to the benefit of humanity and the capital structure of the South African economy. In addition, Pharmaceutical innovations permit unlikely partnerships that reveal the inadequacies of current public health programs and attempt to reform the global procedures related to drug pricing and the types of medical and philanthropic interventions (Biehl, 2007) available to the poor and underprivileged.

The goals of this dissertation are divided into primary and secondary objectives. The primary objective of the study is to determine whether a management framework can be developed to manage capital structure for optimal value creation for companies listed under the Pharmaceutical and Biotechnology sector on the JSE (Johannesburg Stock Exchange).